The Bacterial Vaginosis Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size for bacterial vaginosis has seen substantial growth in recent years. It is projected to increase from $3.03 billion in 2024 to $3.32 billion in 2025, with a compound annual growth rate (CAGR) of 9.7%.
In 2029, the bacterial vaginosis market size is expected to reach $4.75 billion, growing at a compound annual growth rate (CAGR) of 9.4%.
Download Your Free Sample of the 2025 Bacterial Vaginosis Market Report and Uncover Key Trends Now!The key drivers in the bacterial vaginosis market are:
• Increasing prevalence of bacterial vaginosis
• Rising demand for functional foods
• Increasing incidence of sexually transmitted infections
• Rising awareness and focus on women's health and menopause conditions
The bacterial vaginosis market covered in this report is segmented –
1) By Type: Point-Of-Care Testing, Laboratory Testing, Other Types
2) By Product: Below 15 Years, Between 15-45, Other Products
3) By Application: Antibiotics, Other Applications
4) By End-User: Hospitals, Homecare, Specialty Clinics, Other End Users
Subsegments:
1) By Point-Of-Care Testing: Rapid Diagnostic Tests, Microscopy-based Tests, Immunoassays
2) By Laboratory Testing: Gram Staining, Polymerase Chain Reaction (PCR), DNA Probe Tests, Culture-based Testing
3) By Other Types: Home Testing Kits, Enzyme-linked Immunosorbent Assay (ELISA)
The key trends in the bacterial vaginosis market are:
• Integration of artificial intelligence in diagnostics is emerging as a significant trend.
• The adoption of probiotics is increasingly becoming influential in the market.
• Advances in home-based sexually transmitted infection testing is gaining momentum.
• The trend of using sustainable materials in women's health devices is shaping the future of the market.
Major players in the bacterial vaginosis market are:
• Pfizer Inc.
• Merck & Co. Inc.
• Merck KGaA
• Bayer AG
• Sanofi SA
• Thermo Fisher Scientific
• Becton Dickinson
• Viatris Inc.
• Otsuka Pharmaceutical
• LabCorp
• Quest Diagnostics
• Organon & Co.
• UT Southwestern Medical Center
• Hologic Inc.
• bioMérieux SA
• Shionogi & Company Limited
• Melinta Therapeutics Inc.
• Evofem Biosciences
• Gedea Biotech
• Fleurstat
• Medical Diagnostic Laboratories
North America was the largest region in the bacterial vaginosis market in 2024